Avidity Partners Management LP Atai Life Sciences N.V. Transaction History

Avidity Partners Management LP

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$6.82 - $17.8 $1.49 Million - $3.89 Million	-218,730 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$13.62 - $19.48 $1.8 Million - $2.58 Million	-132,257 Reduced 37.68%	218,730 $3.24 Million
Q2 2021 Aug 16, 2021	BUY	$16.94 - $19.89 $5.95 Million - $6.98 Million	350,987 New	350,987 $6.49 Million

12.8M

9.2K

118K

Ticker ATAI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 165,875,008
Market Cap $189M
Description
Atai Life Sciences N.V., through its subsidiary, ATAI Life Sciences AG, operates as a clinical-stage biopharmaceutical company. It engages in developing various therapeutic candidates that focuses on various mental health disorders. The company's therapeutic candidates include PCN-101, a subcutaneous formulation of R-ketamine for the treatment o...

Get notified when there are updates to the investment portfolio of Avidity Partners Management LP, based on Form 13F filings with the SEC.

Stay updated on Avidity Partners Management LP with notifications on news.